Real-time enrollment status for this tourette syndrome clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06315751 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Tourette Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 180 participants |
| Active Locations | 31 sites in the US |
| Sponsor | Noema Pharma AG |
| Last Updated on CT.gov | December 5, 2025 (Dec 5, 2025) |
As of March 2, 2026: Clinical trial NCT06315751 is currently active_not_recruiting participants. This clinical trial study for tourette syndrome is not currently accepting new participants at 31 locations across the United States. The study is sponsored by Noema Pharma AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06315751 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06315751 was last updated Dec 5, 2025 (December 5, 2025). HelloStudys verifies this status automatically.